Swedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascular Mortality

Oncology Times Broadcast News
06/10/2009 4 min

Listen "Swedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascular Mortality"

Descargar episodio Ver en sitio original

Episode Synopsis

Oncology Times Broadcast News

Swedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascular Mortality

Mieke Van Hemelrijck at ECCO15-ESMO34 on findings that cardiovascular mortality from heart failure and arrhythmia in addition to ischemic heart disease and myocardial infarction increased among patients treated with endocrine therapy—of whatever type—for their prostate cancer.

More episodes of the podcast Oncology Times Broadcast News

Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue! 06/10/2009
Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome 28/09/2009
For Early Breast Cancer, Switch to Aromatase Inhibitor after Tamoxifen Extends Survival 28/09/2009
Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Therapy For Early Colon Cancer 28/09/2009
"Promising Activity" Of Cetuximab In Patients With Advanced Biliary Cancer 28/09/2009
Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos 28/09/2009
Stage IV Pancreatic Islet Cell Tumors: Sunitinib Monotherapy Increased Progression Free Survival 28/09/2009
Colorectal Cancer: KRAS-Driven Selection Of Molecular Therapy Could Save Millions: Bevacizumab, Cetuximab, Panitumomab, or Combinations? 28/09/2009
Chronic Myeloid Leukemia 'To Become A Very Indolent Disease': Pregnancy Possible, Transplants Avoided—Mission Accomplished? 28/09/2009
The Smartest Oncologist In The World? 28/09/2009
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA